Authors:
Keller, C
Steensberg, A
Pilegaard, H
Osada, T
Saltin, B
Pedersen, BK
Neufer, PD
Citation: C. Keller et al., Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content, FASEB J, 15(12), 2001, pp. NIL_4-NIL_18
Authors:
Juel, C
Pilegaard, H
Nielsen, JJ
Bangsbo, J
Citation: C. Juel et al., Interstitial K+ in human skeletal muscle during and after dynamic graded exercise determined by microdialysis, AM J P-REG, 278(2), 2000, pp. R400-R406
Authors:
Pilegaard, H
Ordway, GA
Saltin, B
Neufer, PD
Citation: H. Pilegaard et al., Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise, AM J P-ENDO, 279(4), 2000, pp. E806-E814
Authors:
Pilegaard, H
Terzis, G
Halestrap, A
Juel, C
Citation: H. Pilegaard et al., Distribution of the lactate/H+ transporter isoforms MCT1 and MCT4 in humanskeletal muscle, AM J P-ENDO, 39(5), 1999, pp. E843-E848
Authors:
Pilegaard, H
Domino, K
Noland, T
Juel, C
Hellsten, Y
Halestrap, AP
Bangsbo, J
Citation: H. Pilegaard et al., Effect of high-intensity exercise training on lactate/H+ transport capacity in human skeletal muscle, AM J P-ENDO, 39(2), 1999, pp. E255-E261
Authors:
Wallentin, L
Swahn, E
Kontny, F
Husted, S
Lagerqvist, B
Stahle, E
Nielsen, JD
Dellborg, M
Geiran, O
Grande, P
Hulting, J
Kyst-Madsen, J
Nordrehaug, JE
Naslund, U
Pilegaard, H
Rollag, A
Nielsen, TT
Saetre, H
Siegbahn, A
Ohlin, H
Arbeus, M
Bylund, H
Ekstrom, SL
Eriksson, GP
Geiran, O
Holmgren, A
Kellerth, T
Kyst-Madsen, J
Lindblom, D
Lindvall, B
Nordrehaug, J
Pilegaard, H
Radegran, K
Sjogren, I
Stenport, G
Stahl, E
Svane, B
Svedjeholm, R
Toftegaard-Nielsen, T
Hassan, SY
Naslund, U
Persson, S
Jacobsson, KA
Thygesen, K
von der Lippe, G
Julian, D
Bertrand, M
Wedel, H
Andren, B
Diderholm, E
Frostfeldt, G
Jernberg, T
Dellborg, M
Abrahamsson, P
Lindahl, B
Jernberg, T
Siegbahn, A
Venge, P
Swahn, E
Janzon, M
Logander, E
Svensson, E
Lindstrom, G
Alsjo, G
Gulin, M
Setterberg, G
Wikstrom, L
Andersen, IM
Seim, T
Citation: L. Wallentin et al., Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study, LANCET, 354(9180), 1999, pp. 701-707
Authors:
Wallentin, L
Swahn, E
Kontny, F
Husted, S
Lagerqvist, B
Stahle, E
Nielsen, JD
Dellborg, M
Geiran, O
Grande, P
Hulting, J
Kyst-Madsen, J
Nordrehaug, JE
Naslund, U
Pilegaard, H
Rollag, A
Nielsen, TT
Saetre, H
Siegbahn, A
Ohlin, H
Lagerqvist, B
Arbeus, M
Bylund, H
Ekstrom, L
Eriksson, P
Geiran, O
Holmgren, A
Kellerth, T
Kyst-Madsen, J
Lindblom, D
Lindvall, B
Nordrehaug, J
Pilegaard, H
Radegran, K
Sjogren, I
Stenport, G
Stahl, E
Svane, B
Svedjeholm, R
Toftegaard-Nielsen, T
Hassan, SY
Naslund, U
Persson, S
Jacobsson, KA
Thygesen, K
von der Lippe, G
Julian, D
Bertrand, M
Wedel, H
Andren, B
Diderholm, E
Frostfeldt, G
Jernberg, T
Dellborg, M
Abrahamsson, P
Lindahl, B
Jernberg, T
Siegbahn, A
Venge, P
Swahn, E
Janzon, M
Logander, E
Svensson, E
Lindstrom, G
Alsjo, G
Gulin, M
Setterberg, G
Wikstrom, L
M-Andersen, I
Seim, T
Citation: L. Wallentin et al., Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study, LANCET, 354(9180), 1999, pp. 708-715